This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sandra Marie Joseph Ulsemer: Innovator in Antibacterial Compounds
Introduction
Sandra Marie Joseph Ulsemer is a notable inventor based in Village-Neuf, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. Her innovative work focuses on creating novel compounds that can combat bacterial infections effectively.
Latest Patents
Ulsemer holds a patent for "Imidazole-pyrazole derivatives as antibacterials." This invention provides novel imidazole pyrazole derivatives characterized by a specific general formula, along with their pharmaceutically acceptable salts. The patent outlines pharmaceutical compositions that include these compounds, processes for manufacturing them, and methods for their use as medicaments. In particular, these compounds are designed to serve as antibiotics for the treatment or prevention of bacterial infections and related diseases.
Career Highlights
Sandra Marie Joseph Ulsemer is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her work at this esteemed organization has allowed her to contribute to groundbreaking research and development in the field of antibacterial treatments.
Collaborations
Ulsemer has collaborated with notable colleagues, including Christian D Lerner and Mingming Li. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.
Conclusion
Sandra Marie Joseph Ulsemer is a pioneering inventor whose work in developing antibacterial compounds has the potential to significantly impact public health. Her contributions to the pharmaceutical industry exemplify the importance of innovation in combating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
